| Literature DB >> 27181905 |
Ting Xu1,2, Jing Zhao3, Zhifa Xu2, Ruijie Pan2, Daqiang Yin2.
Abstract
Pentachlorophenol (PCP) is a typical toxicant and prevailing pollutant whose toxicity has been broadly investigated. However, previous studies did not specifically investigate the underlying mechanisms of its developmental toxicity. Here, we chose zebrafish embryos as the model, exposed them to 2 different concentrations of PCP, and sequenced their entire transcriptomes at 10 and 24 hours post-fertilization (hpf). The sequencing analysis revealed that high concentrations of PCP elicited systematic responses at both time points. By combining the enrichment terms with single genes, the results were further analyzed using three categories: metabolism, transporters, and organogenesis. Hyperactive glycolysis was the most outstanding feature of the transcriptome at 10 hpf. The entire system seemed to be hypoxic, although hypoxia-inducible factor-1α (HIF1α) may have been suppressed by the upregulation of prolyl hydroxylase domain enzymes (PHDs). At 24 hpf, PCP primarily affected somitogenesis and lens formation probably resulting from the disruption of embryonic body plan at earlier stages. The proposed underlying toxicological mechanism of PCP was based on the crosstalk between each clue. Our study attempted to describe the developmental toxicity of environmental pollutants from a systematic view. Meanwhile, some features of gene expression profiling could serve as markers of human health or ecological risk.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27181905 PMCID: PMC4867433 DOI: 10.1038/srep25929
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The diagram of exposure experimental design.
Figure 2Differentially expressed genes in the four treatment groups.
The genes were grouped based on the changes in their expression levels in response to different PCP concentrations and exposure durations. (a) Bar charts show the numbers of upregulated and downregulated genes. (b) The Venn diagram emphasizes the overlap between the significantly differentially expressed genes in the different groups.
Top 10 upregulated annotated mRNA transcripts in the different PCP-treated groups.
| Group | Symbol | Accession | Description | BLAST | FC |
|---|---|---|---|---|---|
| 10H | |||||
| 1 | NM_213310 | egl-9 family hypoxia-inducible factor 3 | EGLN3 | 97.12 | |
| 2 | NM_213094 | glyceraldehyde-3-phosphate dehydrogenase, spermatogenic | GAPDHS | 76.23 | |
| 3 | NM_212722 | enolase 1a, (alpha) | ENO1 | 64.19 | |
| 4 | XP_688016 | egl-9 family hypoxia-inducible factor 2 | EGLN2 | 42.74 | |
| 5 | XP_002667169 | solute carrier family 2 (facilitated glucose transporter), member 3b | SLC2A1 | 42.08 | |
| 6 | NM_173283 | insulin-like growth factor binding protein 1a | IGFBP1 | 37.75 | |
| 7 | XP_001922963 | sodium- and chloride-dependent creatine transporter 1-like | SLC6A8 | 37.07 | |
| 8 | XP_009292645 | immunoglobulin superfamily DCC subclass member 3-like | IGDCC3 | 29.05 | |
| 9 | XP_001332264 | FYVE, RhoGEF and PH domain-containing protein 4-like | FGD4 | 21.04 | |
| 10 | NM_200410 | solute carrier family 16 (monocarboxylic acid transporters), member 9a | SLC16A9 | 20.17 | |
| 10L | |||||
| 1 | XP_683216 | rho GTPase-activating protein 22-like | ARHGAP22 | 33.72 | |
| 2 | NM_198069 | retinol dehydrogenase 1 | RDH5 | 18.83 | |
| 3 | NM_001030253 | B-cell CLL/lymphoma 2a | BCL2 | 14.33 | |
| NM_001037102 | solute carrier family 8 (sodium/calcium exchanger), member 1a | SLC8A1 | 14.33 | ||
| 5 | NM_001302776 | lens epithelial protein | 13.49 | ||
| XP_003201273 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent | NFATC2 | 13.49 | ||
| NM_001199362 | cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | CILP | 13.49 | ||
| 8 | NM_001159839 | calsyntenin 2 | CLSTN2 | 12.65 | |
| 9 | NM_001045386 | UDP glucuronosyltransferase 5 family, polypeptide C2 | UGT2A1 | 12.22 | |
| 10 | NM_212606 | cadherin 15, M-cadherin (myotubule) | CDH15 | 11.80 | |
| 24H | |||||
| 1 | NM_001265607 | mesoderm posterior bb | 218.33 | ||
| 2 | XP_003201455 | mesoderm posterior protein 2-like | MESP2 | 208.25 | |
| 3 | NM_131078 | hairy-related 1 | HES7 | 137.44 | |
| 4 | NM_001089325 | alanyl (membrane) aminopeptidase b | ANPEP | 128.30 | |
| 5 | NM_131551 | mesoderm posterior aa | MESP2 | 99.29 | |
| 6 | XP_001346314 | solute carrier family 7 (amino acid transporter light chain, L system) | SLC7A8 | 94.66 | |
| 7 | NM_131058 | T-box 16 | TBX6 | 85.61 | |
| 8 | NM_182882 | mesogenin 1 | MSGN1 | 80.36 | |
| 9 | NM_131354 | SIX homeobox 7 | SIX3 | 75.10 | |
| 10 | NM_153666 | T-box 6 | TBX6 | 64.34 | |
| 24L | |||||
| 1 | XP_009294016 | solute carrier family 22 (organic cation/carnitine transporter), member | SLC22A5 | 31.81 | |
| 2 | XP_691153 | regulator of G-protein signaling 9 binding protein | RGS9BP | 22.17 | |
| 3 | NM_131078 | hairy-related 1 | HES7 | 17.74 | |
| 4 | XP_001346314 | solute carrier family 7 (amino acid transporter light chain, L system) | SLC7A8 | 17.35 | |
| 5 | XP_005164589 | ubl carboxyl-terminal hydrolase 18-like | USP18 | 14.46 | |
| 6 | XP_698750 | finTRIM family, member 7 | TRIM25 | 13.50 | |
| 7 | XP_003201455 | mesoderm posterior protein 2-like | MESP2 | 11.57 | |
| NM_001265607 | mesoderm posterior bb | 11.57 | |||
| 8 | XP_005173582 | interferon-inducible GTPase 5-like | IRGC | 10.60 | |
| NM_001145630 | leucine-rich repeat, immunoglobulin-like and transmembrane domains | LRIT3 | 10.60 | ||
| 10 | NM_131700 | ventral expressed homeobox | VENTX | 10.51 | |
Figure 3GO trees based on the hierarchies between the significant terms in the GO database.
Only direct ancestors and child relationships were adopted, and the arrows point to the child terms. The colors of the balls represent the significance levels of terms. The six graphs include the BP terms in the (a) 10H group and (b) 24H group, the MF terms in the (c) 10H group and (d) 24H group, and the CC terms in the (e) 10H group and (f) 24H group.
Figure 4Top 20 enriched KEGG pathway terms of the four PCP-treated groups.
The columns are graphed based on their enrichment levels, and the lines represent the p-values. (a) 10L group. (b) 10H group. (c) 24L group. (d) 24H group.
Figure 5Proportions of individual categories of KEGG pathway terms.
(a) 10L group. (b) 10H group. (c) 24L group. (d) 24H group.
Figure 6A proposed mechanical framework for PCP developmental toxicity.
The vertical direction represents the progression of the toxic effects along with the causal biological events. The horizontal direction represents the approximate timeline of embryonic development and chemical exposure. The abbreviation “AA” in framework indicated amino acid.
Comparison of the changes in gene expression between the RNA sequencing and qRT-PCR data (200 μg/l PCP).
| log2FC (10 hpf) | log2FC (24 hpf) | |||
|---|---|---|---|---|
| Sequencing | qRT-PCR | Sequencing | qRT-PCR | |
| gapdhs | 6.25 | 4.79 | 1.74 | 0.69 |
| egln3 | 6.60 | 4.97 | 3.27 | 2.14 |
| mespa | 1.43 | 1.66 | 6.63 | 3.77 |
| cox7a2 | n/a | −0.22 | −1.99 | −2.43 |
| abcb11a | −1.25 | −1.14 | 4.77 | 2.45 |
| atp5ia | n/a | −0.46 | −2.44 | −2.81 |
| cryba2b | n/a | 0.22 | −5.40 | −4.52 |
| gnb5b | 1.70 | 1.60 | −3.55 | −3.97 |
| ldha | 3.25 | 2.00 | n/a | −0.74 |
| scn1ba | n/a | −0.24 | −1.53 | −2.72 |
| her1 | n/a | 0.81 | 7.10 | 4.02 |
| abcc8 | 1.59 | 1.57 | −3.12 | −3.67 |
| kcnc3b | 3.70 | 2.35 | −1.90 | −2.01 |
aFailed to pass the significance test when the RNA sequencing data were analyzed.
Validation of the PCP concentrations before and after exposure.
| Nominal | Beginning | End | ||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| 200 | 178.00 | 3.26 | 112.57 | 2.95 |